74
27
TH
CONGRESS OF THE ESPU
11:35–11:38
S24-2 (PP)
IS THERE A CHARACTERISTIC UROFLOW PATTERN FOR OVERACTIVE BLADDER (OAB)
Kenneth GLASSBERG
1
, Jason VAN BATAVIA
2
and Andrew COMBS
3
1 Columbia UniversityMedical Center, Urology, Remsenburg, USA
2 The Children’s Hospital of Philadelphia, Pediatric Urology, Philadelphia, USA
3 Weill Cornell Medical Center, Urology, New York, USA
11:38–11:41
S24-3 (PP)
A NON-INVASIVE APPROACH TO DETERMINE THE TYPE AND SEVERITY OF VOIDING-DEFECATION
DYSFUNCTIONS IN CHILDREN FOR A FAVORABLE OUTCOME
Abdurrahman ONEN
Onen Cocuk Urolojisi Merkezi, Paediatric Surgery, Diyarbakir, TURKEY
11:41–11:44
S24-4 (PP)
THE ROLE OF STRUCTERED BIOFEEDBACK IN THE TREATMENT OF VOIDING DYSFUNCTION:
WHEN AND HOW BIOFEEDBACK?
Abdurrahman ONEN
Onen Cocuk Urolojisi Merkezi, Paediatric Urology, Diyarbakir, TURKEY
11:44–11:47
S24-5 (PP)
THE EFFECT OF BIOFEEDBACK THERAPY ON VOIDING DYSFUNCTION SYMPTOM SCORE IN CHILDREN
WITH LOWER URINARY TRACT DYSFUNCTION
Bahadir TOPUZ
1
, Giray ERGIN
2
, Sercan YILMAZ
1
, Hasan Cem IRKILATA
1
, Yusuf KIBAR
1
and Musa Murat DAYANÇ
3
1 Gülhane military medical academy, Urology, Ankara, TURKEY
2 Koru hospital, Urology, Ankara, TURKEY
3 Liv hospital, Pediatric urology, Ankara, TURKEY
11:47–12:08
Discussion
ESPU Meeting on Saturday 25, June 2016, 12:08–12:56
S25: NEUROPATHIC BLADDER
Moderators: Antonio Macedo (Brazil), Raimund Stein (Germany)
12:08–12:11
S25-1 (PP)
DETERMINING WHICH SPINA BIFIDA PATIENTS WITH AN ELEVATED DETRUSOR LEAK POINT
PRESSURE (DLPP) ARE AT GREATEST RISK FOR DEVELOPING UPPER TRACT COMPROMISE: THE VALUE
OF THE “REINSERTION TECHNIQUE”
Kenneth GLASSBERG
1
and Andrew COMBS
2
1 Columbia University Medical Center, Urology, Remsenburg, USA
2 Weill Cornell Medical Center, Urology, New York, USA